AI-generated analysis. Always verify with the original filing.
Cocrystal Pharma, Inc. filed an 8-K on February 19, 2026, including a press release as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' for purposes of Section 18 of the Exchange Act. No specific event details or Item 7.01 content are disclosed in the provided document.
Event Type
Disclosure
Voluntary
Variant
8-K
(including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject
Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release dated February 19, 2026 104 Cover Page Interactive Data File (embedded wi